DNA fundamentals
An in-depth look to GINKGO BIOWORKS HOLDINGS, INC operating, investing, and financing activities
DNA free cash flow for Q1 24 is -1.59 B MXN. For 2023, DNA free cash flow was -5.71 B MXN and operating cash flow was -5.02 B MXN.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: MXN
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM